Education
About Us
Working with TipRanks
Follow Us
Palatin Technologies (PTN)
XASE:PTN
PTN Stock Chart & Stats
$11.04
--
Market closed
$11.04
--
Day’s Range― - ―
52-Week Range$1.77 - $72.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)2.99K
Market Cap
$5.72M
Enterprise Value$4.11M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Nov 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.40
Shares Outstanding973,291
10 Day Avg. Volume2,746
30 Day Avg. Volume2,993
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.72
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Palatin Technologies News
PTN FAQ
What was Palatin Technologies’s price range in the past 12 months?
Palatin Technologies lowest stock price was $1.77 and its highest was $72.50 in the past 12 months.
What is Palatin Technologies’s market cap?
Palatin Technologies’s market cap is $5.72M.
When is Palatin Technologies’s upcoming earnings report date?
Palatin Technologies’s upcoming earnings report date is Nov 17, 2025 which is in 4 days.
How were Palatin Technologies’s earnings last quarter?
Currently, no data Available
Is Palatin Technologies overvalued?
According to Wall Street analysts Palatin Technologies’s price is currently Overvalued.
Does Palatin Technologies pay dividends?
Palatin Technologies does not currently pay dividends.
What is Palatin Technologies’s EPS estimate?
Palatin Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Palatin Technologies have?
Palatin Technologies has 973,291 shares outstanding.
What happened to Palatin Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Palatin Technologies?
Currently, no hedge funds are holding shares in PTN
Company Description
Palatin Technologies
Palatin Technologies, Inc. is a biopharmaceutical company focused on developing targeted receptor-specific therapeutics for the treatment of various medical conditions. The company primarily operates in the biotechnology sector, with a strong emphasis on developing treatments for inflammatory diseases and disorders related to sexual dysfunction. Palatin's core product includes Vyleesi, a melanocortin receptor agonist indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).
Technical Analysis
Ibio
―
Phio Pharmaceuticals
―
BioRestorative Therapies
―
Addex Therapeutics
―
Bolt Biotherapeutics
―